Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  04:00PM ET
91.94
Dollar change
-0.47
Percentage change
-0.51
%
Feb 10, 9:06 AMBillionToOne launches Northstar PGx and Northstar Select CH as new add-on liquid biopsy applications for its Northstar Select platform to expand oncology testing capabilities.
Index- P/E- EPS (ttm)-0.32 Insider Own54.28% Shs Outstand41.22M Perf Week11.19%
Market Cap4.21B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float20.93M Perf Month6.98%
Enterprise Value4.54B PEG- EPS next Q0.06 Inst Own4.90% Short Float4.41% Perf Quarter-8.09%
Income-14.20M P/S16.56 EPS this Y- Inst Trans15.28% Short Ratio4.39 Perf Half Y-
Sales254.14M P/B- EPS next Y- ROA- Short Interest0.92M Perf YTD12.34%
Book/sh-5.23 P/C21.56 EPS next 5Y- ROE- 52W High138.70 -33.71% Perf Year-
Cash/sh4.26 P/FCF- EPS past 3/5Y- - ROIC-5.03% 52W Low80.00 14.93% Perf 3Y-
Dividend Est.- EV/EBITDA1982.70 Sales past 3/5Y- - Gross Margin65.15% Volatility6.52% 7.39% Perf 5Y-
Dividend TTM- EV/Sales17.87 EPS Y/Y TTM- Oper. Margin-2.36% ATR (14)6.42 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.75 Sales Y/Y TTM- Profit Margin-5.59% RSI (14)53.95 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio6.17 EPS Q/Q109.87% SMA204.82% Beta- Target Price135.29
Payout- Debt/Eq0.60 Sales Q/Q117.40% SMA50-1.75% Rel Volume1.03 Prev Close92.41
Employees- LT Debt/Eq0.57 EarningsDec 09 AMC SMA200-4.36% Avg Volume210.14K Price91.94
IPONov 06, 2025 Option/ShortNo / Yes EPS/Sales Surpr.-28.32% 0.72% Trades Volume216,286 Change-0.51%
Date Action Analyst Rating Change Price Target Change
Jan-06-26Initiated Guggenheim Buy $120
Dec-01-25Initiated William Blair Outperform
Dec-01-25Initiated Wells Fargo Equal Weight $110
Dec-01-25Initiated Stifel Buy $145
Dec-01-25Initiated Piper Sandler Overweight $150
Dec-01-25Initiated JP Morgan Overweight $150
Dec-01-25Initiated Jefferies Hold $117
Dec-01-25Initiated BTIG Research Buy $160
Feb-10-26 09:00AM
Feb-09-26 12:29PM
Jan-23-26 10:23AM
Jan-15-26 08:58AM
Jan-13-26 09:43AM
04:24AM Loading…
04:24AM
Jan-12-26 08:05AM
Jan-06-26 09:00AM
Jan-01-26 12:13AM
Dec-23-25 08:05AM
Dec-09-25 04:07PM
04:05PM
07:10AM
Dec-03-25 04:00PM
Dec-02-25 08:05AM
12:16PM Loading…
Dec-01-25 12:16PM
09:46AM
Nov-26-25 12:59PM
Nov-25-25 05:00PM
Nov-18-25 12:34AM
Nov-07-25 04:05PM
Nov-06-25 05:02PM
03:39PM
Nov-05-25 09:53PM
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. BillionToOne was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.